Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Science signaling

Showing results (751-760 of 3,167) with videos related to

Pageof 317
Sort By:
Science Signaling|May 25, 2012
Interferon-β therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasomeMakoto Inoue, Kristi L Williams, Timothy Oliver, et al.
Science Signaling|July 4, 2013
Estrogen alters the splicing of type 1 corticotropin-releasing hormone receptor in breast cancer cellsSuchita Lal, Anna Allan, Danijela Markovic, et al.
Science Signaling|July 4, 2013
A kinetic test characterizes kinase intramolecular and intermolecular autophosphorylation mechanismsCharlotte A Dodson, Sharon Yeoh, Tamanna Haq, et al.
Science Signaling|June 14, 2012
S-nitrosylation signaling in Escherichia coliIvan Gusarov, Evgeny Nudler
Science Signaling|December 25, 2014
RAS signaling promotes resistance to JAK inhibitors by suppressing BAD-mediated apoptosisPeter S Winter, Kristopher A Sarosiek, Kevin H Lin, et al.
Science Signaling|August 21, 2014
Outflanking RANK with a designer antagonist cytokineChih-Wen Ou-Yang, Richard M Siegel
Science Signaling|October 24, 2013
Antidiabetic sulfonylureas and cAMP cooperatively activate Epac2AToshimasa Takahashi, Tadao Shibasaki, Harumi Takahashi, et al.
Science Signaling|November 22, 2012
Sequential conformational rearrangements dictate the dynamics of class C GPCR activationJ Robert Lane, Meritxell Canals
Science Signaling|November 22, 2012
Attractor landscape analysis reveals feedback loops in the p53 network that control the cellular response to DNA damageMinsoo Choi, Jue Shi, Sung Hoon Jung, et al.
Science Signaling|September 10, 2015
Identification of potential drug targets for tuberous sclerosis complex by synthetic screens combining CRISPR-based knockouts with RNAiBenjamin E Housden, Alexander J Valvezan, Colleen Kelley, et al.
Pageof 317

Showing results (751-760 of 3,167) with videos related to

Sort By:
Pageof 317
Science Signaling|May 25, 2012
Interferon-β therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasomeMakoto Inoue, Kristi L Williams, Timothy Oliver, et al.
Science Signaling|July 4, 2013
Estrogen alters the splicing of type 1 corticotropin-releasing hormone receptor in breast cancer cellsSuchita Lal, Anna Allan, Danijela Markovic, et al.
Science Signaling|July 4, 2013
A kinetic test characterizes kinase intramolecular and intermolecular autophosphorylation mechanismsCharlotte A Dodson, Sharon Yeoh, Tamanna Haq, et al.
Science Signaling|June 14, 2012
S-nitrosylation signaling in Escherichia coliIvan Gusarov, Evgeny Nudler
Science Signaling|December 25, 2014
RAS signaling promotes resistance to JAK inhibitors by suppressing BAD-mediated apoptosisPeter S Winter, Kristopher A Sarosiek, Kevin H Lin, et al.
Science Signaling|August 21, 2014
Outflanking RANK with a designer antagonist cytokineChih-Wen Ou-Yang, Richard M Siegel
Science Signaling|October 24, 2013
Antidiabetic sulfonylureas and cAMP cooperatively activate Epac2AToshimasa Takahashi, Tadao Shibasaki, Harumi Takahashi, et al.
Science Signaling|November 22, 2012
Sequential conformational rearrangements dictate the dynamics of class C GPCR activationJ Robert Lane, Meritxell Canals
Science Signaling|November 22, 2012
Attractor landscape analysis reveals feedback loops in the p53 network that control the cellular response to DNA damageMinsoo Choi, Jue Shi, Sung Hoon Jung, et al.
Science Signaling|September 10, 2015
Identification of potential drug targets for tuberous sclerosis complex by synthetic screens combining CRISPR-based knockouts with RNAiBenjamin E Housden, Alexander J Valvezan, Colleen Kelley, et al.
Pageof 317